FDA Approved: SIRTURO — Original Application (Janssen Products, LP)

View source ↗

Summary

FDA approved SIRTURO (bedaquiline fumarate) from Janssen as the original application for the treatment of multidrug-resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• SIRTURO (bedaquiline fumarate)

Snippet

ORIG AP for SIRTURO (BEDAQUILINE FUMARATE)